Public Company

ChromaDex, Inc.


ChromaDex is a bioscience company dedicated to the support and development of healthy aging. The company has initiatives in research related to nicotinamide adenine dinucleotide (NAD+), which is found in every cell as we age. Being known for its active role in cellular energy production, NAD+ is now thought to hold an important role in healthy aging, as it is an essential coenzyme and key regulator of cellular metabolism and is required for efficient and proper mitochondrial function.


Founded 1999
Type Public
Location Los Angeles, California, USA


CDXC $2.12 8.46% $0.17

Latest News

Down 9.6% in 4 Weeks, Here's Why ChromaDex (CDXC) Looks Ripe for a Turnaround Dec 19, 2022 Zacks Investment Research The heavy selling pressure might have exhausted for ChromaDex (CDXC) as it is technically in oversold territory now. In addition to this technical measure, strong...
Here's Why ChromaDex (CDXC) is Poised for a Turnaround After Losing 7.5% in 4 Weeks Dec 16, 2022 Zacks Investment Research ChromaDex (CDXC) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among...
Why Party City Holdco Shares Tumbled Over 40%; Here Are 98 Biggest Movers From Yesterday Nov 09, 2022 Benzinga Gainers Unique Fabricating, Inc. (NYSE: UFAB) jumped 56.3% to close at $0.8205 on Tuesday. Unique Fabricating posted a Q3 loss of $0.90 per share after... featured highlights Oxford Industries, ChromaDex, UserTesting and TravelCenters of America Nov 09, 2022 Zacks Investment Research Oxford Industries, ChromaDex, UserTesting and TravelCenters of America have been highlighted in this Screen of The Week article.
Why TaskUs Shares Are Trading Higher By 37%? Here Are 77 Stocks Moving In Tuesday's Mid-Day Session Nov 08, 2022 Benzinga Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares jumped 39.4% to $1.4529 after the company announced a payment assignment from the Centers for Medicare & Medicaid...